Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?

Detalles Bibliográficos
Autores principales: Di Noia, Vincenzo, Pimpinelli, Fulvia, Renna, Davide, Campo, Flaminia, Cosimati, Antonella, Torchia, Andrea, Marcozzi, Benedetta, Massacci, Alice, Pallocca, Matteo, Pellini, Raul, Morrone, Aldo, Cognetti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548024/
https://www.ncbi.nlm.nih.gov/pubmed/36223679
http://dx.doi.org/10.1016/j.ejca.2022.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548024/
https://www.ncbi.nlm.nih.gov/pubmed/36223679
http://dx.doi.org/10.1016/j.ejca.2022.09.006

Ejemplares similares